Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesDetection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT
European Journal of Nuclear Medicine & Molecular Imaging, 06/09/09
Krüger S et al. - In a study to compare diagnostic accuracy of 18F-fluorodeoxyglucose (FDG) PET/CT vs standard planar bone scintigraphy (BS) and 18F-labelled NaF (18F) PET for detection of bone metastases (BM) in non-small cell lung cancer (NSCLC), it was concluded that integrated 18F-FDG PET/CT is superior to BS in detection of osteolytic BM in NSCLC. PET/CT may obviate the need to perform additional BS or 18F PET in staging of NSCLC, which significantly reduces costs.
Methods- 18F-FDG PET/CT was performed in 126 pts with NSCLC.
- Within 7 days BS (n=58) or 18F PET (n=68) was performed.
- 18F-FDG PET/CT, BS and 18F PET were evaluated by 2 experienced readers.
- Lesions were graded on a scale from 1 (definite BM) to 5 (degenerative lesion), and equivocal lesions were determined as indifferent (grade 3).
- 92 pts showed degenerative lesions (grade 4/5) on PET/CT, BS or 18F PET.
- In 34 pts (27%), BM lesions were diagnosed (grades 1 and 2).
- In 13 of 18 pts, BM were concordantly diagnosed with PET/CT and 18F PET.
- PET/CT showed more BM vs 18F PET (53 vs 40).
- In 1 pt, 1 osteolytic BM was false-negative on 18F PET.
- 18F PET identified 4 pts with BM compared with negative findings on PET/CT.
- Of 16 pts, 11 had concordant findings of BM on PET/CT and BS.
- In 3 pts, BS was false-negative and in 2 pts BM were diagnosed as indifferent.
Today in Diagnostic/Lung Function...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of Fluticasone With and Without Salmeterol on Pulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Annals of Internal Medicine, 10/20/09
Severity Staging of Chronic Obstructive Pulmonary Disease: Differences in Pre- and Post-Bronchodilator Spirometry
Yonsei Medical Journal, 10/23/09
Pulmonary function testing in young children
Paediatric Respiratory Reviews, 11/04/09
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Oestrogen plus progestin and lung cancer in postmenopausal women (Womens Health Initiative trial): a post-hoc analysis of a randomised controlled trial
The Lancet, 10/12/09
Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer
Annals of Oncology, 10/19/09
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: A randomised, double-blind, phase III study
The Lancet, 10/26/09
Sponsor
Article Search
Sponsor